Cystic Fibrosis
Showing NaN - NaN of 112
Cystic Fibrosis Trial in United States (Oral Glutathione, Placebo)
Completed
- Cystic Fibrosis
- Oral Glutathione
- Placebo
-
Aurora, Colorado
- +17 more
Dec 20, 2019
Patient-reported Gastrointestinal Symptoms in People With Cystic
Completed
- Cystic Fibrosis
-
Palo Alto, California
- +25 more
Oct 1, 2019
Cystic Fibrosis Trial in United States (Arikayce™ 560 mg, Placebo for 560 mg, Arikayce™ 70 mg)
Completed
- Cystic Fibrosis
- Arikayce™ 560 mg
- +4 more
-
Birmingham, Alabama
- +18 more
May 14, 2019
Cystic Fibrosis Trial in United States (Gallium nitrate, Normal Saline)
Completed
- Cystic Fibrosis
- Gallium nitrate
- Normal Saline
-
Birmingham, Alabama
- +22 more
Mar 20, 2019
The EPIC Observational Study
Completed
- Cystic Fibrosis
-
Birmingham, Alabama
- +53 more
Jan 30, 2019
A Multi-Center Study of the CF Quantum® Sweat Test System
Terminated
- Cystic Fibrosis
- Iontophoresis sweat test
-
Birmingham, Alabama
- +5 more
Aug 28, 2018
A Study of Sweat Testing Using a Quantitative Patch
Completed
- Cystic Fibrosis
-
Minneapolis, Minnesota
- +2 more
Aug 28, 2018
Cystic Fibrosis Trial in Worldwide (VX-661/Ivacaftor, Ivacaftor, Placebo matched to VX-661/ ivacaftor)
Cystic Fibrosis Trial in Worldwide (VX-661 Plus Ivacaftor Combination, Ivacaftor, VX-661 Plus Ivacaftor Combination Placebo)
Completed
- Cystic Fibrosis
- VX-661 Plus Ivacaftor Combination
- +3 more
-
Little Rock, Arkansas
- +74 more
May 8, 2018
Cystic Fibrosis Trial in Worldwide (VX-661 plus ivacaftor combination, Ivacaftor, Placebo (matched to VX-661 plus ivacaftor
Completed
- Cystic Fibrosis
- VX-661 plus ivacaftor combination
- +3 more
-
Birmingham, Alabama
- +42 more
May 8, 2018
Cystic Fibrosis Trial in Worldwide (MP-376 (Levofloxacin Solution for Inhalation), TIS (Tobramycin Inhalation Solution))
Completed
- Cystic Fibrosis
- MP-376 (Levofloxacin Solution for Inhalation)
- TIS (Tobramycin Inhalation Solution)
-
Mobile, Alabama
- +129 more
Jan 17, 2018
Cystic Fibrosis Trial in Worldwide (MP-376 (Levofloxacin solution for Inhalation), Placebo)
Completed
- Cystic Fibrosis
- MP-376 (Levofloxacin solution for Inhalation)
- Placebo
-
Mobile, Alabama
- +111 more
Jan 17, 2018
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
Completed
- Cystic Fibrosis
-
Minneapolis, MinnesotaUniversity of Minnesota
Jan 11, 2018
Cystic Fibrosis Trial in United States (AquADEKs-2, control multivitamin)
Cystic Fibrosis Trial in United States (Dornase alfa, )
Terminated
- Cystic Fibrosis
- Dornase alfa
- placebo
-
Birmingham, Alabama
- +39 more
May 12, 2017
Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus Trial in United States (Rifampin, Trimethoprim/Sulfamethoxazole,
Terminated
- Cystic Fibrosis
- Methicillin-resistant Staphylococcus Aureus
- Rifampin
- +6 more
-
Birmingham, Alabama
- +12 more
Apr 5, 2017
Monitor Susceptibility to Aztreonam of Pseudomonas Aeruginosa
Completed
- Cystic Fibrosis
-
Anchorage, Alaska
- +30 more
Jan 9, 2017
Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger
Completed
- Cystic Fibrosis
- Ophthalmologic examinations
- Ivacaftor Exposed
-
Birmingham, Alabama
- +37 more
Aug 22, 2016
Cystic Fibrosis Trial in Minneapolis (HFCWC with higher pressure/variable-frequency settings, HFCWC with lower
Completed
- Cystic Fibrosis
- HFCWC with higher pressure/variable-frequency settings
- HFCWC with lower pressure/mid-frequency settings
-
Minneapolis, MinnesotaUniversity of Minnesota Medical Center
Jun 24, 2016